-
Something wrong with this record ?
Nanomaterials with active targeting as advanced antimicrobials
K. Smerkova, K. Dolezelikova, L. Bozdechova, Z. Heger, L. Zurek, V. Adam
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
32363802
DOI
10.1002/wnan.1636
Knihovny.cz E-resources
- MeSH
- Anti-Infective Agents * MeSH
- Bacterial Infections drug therapy MeSH
- Drug Resistance, Bacterial MeSH
- Humans MeSH
- Nanomedicine MeSH
- Nanostructures * MeSH
- Drug Discovery MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
With a growing health threat of bacterial resistance to antibiotics, the nanomaterials have been extensively studied as an alternative. It is assumed that antimicrobial nanomaterials can affect bacteria by several mechanisms simultaneously and thereby overcome antibiotic resistance. Another promising potential use is employing nanomaterials as nanocarriers for antibiotics in order to overcome bacterial defense mechanisms. The passive targeting of nanomaterials is the often used strategy for bacterial treatment, including intracellular infections of macrophages. Furthermore, the specific targeting enhances the efficacy of antimicrobials and reduces side effects. This review aims to discuss advantages, disadvantages, and challenges of nanomaterials in the context of the targeting strategies for antimicrobials as advanced tools for treatments of bacterial infections. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease.
Central European Institute of Technology Brno University of Technology Brno Czech Republic
Department of Chemistry and Biochemistry Mendel University in Brno Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012235
- 003
- CZ-PrNML
- 005
- 20210713123356.0
- 007
- ta
- 008
- 210420s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/wnan.1636 $2 doi
- 035 __
- $a (PubMed)32363802
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Smerkova, Kristyna $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic ; Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic
- 245 10
- $a Nanomaterials with active targeting as advanced antimicrobials / $c K. Smerkova, K. Dolezelikova, L. Bozdechova, Z. Heger, L. Zurek, V. Adam
- 520 9_
- $a With a growing health threat of bacterial resistance to antibiotics, the nanomaterials have been extensively studied as an alternative. It is assumed that antimicrobial nanomaterials can affect bacteria by several mechanisms simultaneously and thereby overcome antibiotic resistance. Another promising potential use is employing nanomaterials as nanocarriers for antibiotics in order to overcome bacterial defense mechanisms. The passive targeting of nanomaterials is the often used strategy for bacterial treatment, including intracellular infections of macrophages. Furthermore, the specific targeting enhances the efficacy of antimicrobials and reduces side effects. This review aims to discuss advantages, disadvantages, and challenges of nanomaterials in the context of the targeting strategies for antimicrobials as advanced tools for treatments of bacterial infections. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease.
- 650 12
- $a antiinfekční látky $7 D000890
- 650 _2
- $a bakteriální infekce $x farmakoterapie $7 D001424
- 650 _2
- $a objevování léků $7 D055808
- 650 _2
- $a bakteriální léková rezistence $7 D024881
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nanomedicína $7 D050997
- 650 12
- $a nanostruktury $7 D049329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Dolezelikova, Kristyna $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic ; Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic
- 700 1_
- $a Bozdechova, Lucie $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic ; Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic
- 700 1_
- $a Heger, Zbynek $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic ; Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic
- 700 1_
- $a Zurek, Ludek $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic ; Central European Institute of Technology, Center for Zoonoses, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic
- 700 1_
- $a Adam, Vojtech $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic ; Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic
- 773 0_
- $w MED00176934 $t Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology $x 1939-0041 $g Roč. 12, č. 5 (2020), s. e1636
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32363802 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210713123354 $b ABA008
- 999 __
- $a ok $b bmc $g 1650579 $s 1132614
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 12 $c 5 $d e1636 $e 20200503 $i 1939-0041 $m Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology $n Wiley Interdiscip Rev Nanomed Nanobiotechnol $x MED00176934
- LZP __
- $a Pubmed-20210420